Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.
Identifieur interne : 000B78 ( Main/Exploration ); précédent : 000B77; suivant : 000B79Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.
Auteurs : Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Brian Godman [Royaume-Uni] ; Santosh Kumar [Inde] ; Salequl Islam [Bangladesh] ; Iffat Jahan [Bangladesh] ; Mainul Haque [Malaisie]Source :
- Infection and drug resistance [ 1178-6973 ] ; 2020.
Abstract
A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and quickly spread globally. Several treatments have been proposed, many of which have proven ineffective. Consequently, there is a need to review the published evidence of drug clinical trials to guide future prescribing. A systematic review of published clinical trials and retrospective observational studies was carried out. The search was made using PubMed, Embase, MEDLINE, and China National Knowledge Infrastructure (CNKI) databases. Articles published between January 2020 and October 2020 and written in the English language were retrieved and included in the study. Researches that used traditional medicine, in-vitro and in-vivo animal studies, as well as reviews were excluded. Seventy-three relevant articles that fulfilled the inclusion criteria were finally selected and reviewed. Hydroxychloroquine, chloroquine, and azithromycin produced no clinical evidence of efficacy in randomized controlled clinical trials (RCT). However, retrospective observational studies reported the efficacy of remdesivir and lopinavir/ritonavir in reducing viral load, although there have been concerns with lopinavir/ritonavir and, more recently, remdesivir. Recently, tocilizumab, dexamethasone, and methylprednisolone significantly relieved lung inflammation and decreased mortality in patients with severe COVID-19. In addition, convalescent plasma was effective in boosting strong immunity among patients with mild COVID-19. There is currently no single worldwide approved therapeutic option for patients with COVID-19 despite the initial hype with medicines, including hydroxychloroquine. Nonetheless, dexamethasone has shown promise in symptomatic treatment and convalescent plasma in boosting immunity. New treatments are currently being researched, and the findings will be reported accordingly to provide evidence-based guidance for prescribers and policymakers.
DOI: 10.2147/IDR.S289037
PubMed: 33402839
PubMed Central: PMC7778508
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.</title>
<author><name sortKey="Abubakar, Abdullahi Rabiu" sort="Abubakar, Abdullahi Rabiu" uniqKey="Abubakar A" first="Abdullahi Rabiu" last="Abubakar">Abdullahi Rabiu Abubakar</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano</wicri:regionArea>
<wicri:noRegion>Kano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sani, Ibrahim Haruna" sort="Sani, Ibrahim Haruna" uniqKey="Sani I" first="Ibrahim Haruna" last="Sani">Ibrahim Haruna Sani</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Pharmacology, College of Health Sciences, Yusuf Maitama Sule University, Kano, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Unit of Pharmacology, College of Health Sciences, Yusuf Maitama Sule University, Kano</wicri:regionArea>
<wicri:noRegion>Kano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Godman, Brian" sort="Godman, Brian" uniqKey="Godman B" first="Brian" last="Godman">Brian Godman</name>
<affiliation wicri:level="1"><nlm:affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow</wicri:regionArea>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kumar, Santosh" sort="Kumar, Santosh" uniqKey="Kumar S" first="Santosh" last="Kumar">Santosh Kumar</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Periodontology and Implantology, Karnavati University, Gandhinagar 382422, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Periodontology and Implantology, Karnavati University, Gandhinagar 382422</wicri:regionArea>
<wicri:noRegion>Gandhinagar 382422</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Islam, Salequl" sort="Islam, Salequl" uniqKey="Islam S" first="Salequl" last="Islam">Salequl Islam</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.</nlm:affiliation>
<country xml:lang="fr">Bangladesh</country>
<wicri:regionArea>Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342</wicri:regionArea>
<wicri:noRegion>Dhaka 1342</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jahan, Iffat" sort="Jahan, Iffat" uniqKey="Jahan I" first="Iffat" last="Jahan">Iffat Jahan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Physiology, Eastern Medical College, Cumilla, Bangladesh.</nlm:affiliation>
<country xml:lang="fr">Bangladesh</country>
<wicri:regionArea>Department of Physiology, Eastern Medical College, Cumilla</wicri:regionArea>
<wicri:noRegion>Cumilla</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Haque, Mainul" sort="Haque, Mainul" uniqKey="Haque M" first="Mainul" last="Haque">Mainul Haque</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000</wicri:regionArea>
<wicri:noRegion>57000</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33402839</idno>
<idno type="pmid">33402839</idno>
<idno type="doi">10.2147/IDR.S289037</idno>
<idno type="pmc">PMC7778508</idno>
<idno type="wicri:Area/Main/Corpus">000554</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000554</idno>
<idno type="wicri:Area/Main/Curation">000554</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000554</idno>
<idno type="wicri:Area/Main/Exploration">000554</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.</title>
<author><name sortKey="Abubakar, Abdullahi Rabiu" sort="Abubakar, Abdullahi Rabiu" uniqKey="Abubakar A" first="Abdullahi Rabiu" last="Abubakar">Abdullahi Rabiu Abubakar</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano</wicri:regionArea>
<wicri:noRegion>Kano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sani, Ibrahim Haruna" sort="Sani, Ibrahim Haruna" uniqKey="Sani I" first="Ibrahim Haruna" last="Sani">Ibrahim Haruna Sani</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Pharmacology, College of Health Sciences, Yusuf Maitama Sule University, Kano, Nigeria.</nlm:affiliation>
<country xml:lang="fr">Nigeria</country>
<wicri:regionArea>Unit of Pharmacology, College of Health Sciences, Yusuf Maitama Sule University, Kano</wicri:regionArea>
<wicri:noRegion>Kano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Godman, Brian" sort="Godman, Brian" uniqKey="Godman B" first="Brian" last="Godman">Brian Godman</name>
<affiliation wicri:level="1"><nlm:affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow</wicri:regionArea>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kumar, Santosh" sort="Kumar, Santosh" uniqKey="Kumar S" first="Santosh" last="Kumar">Santosh Kumar</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Periodontology and Implantology, Karnavati University, Gandhinagar 382422, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Periodontology and Implantology, Karnavati University, Gandhinagar 382422</wicri:regionArea>
<wicri:noRegion>Gandhinagar 382422</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Islam, Salequl" sort="Islam, Salequl" uniqKey="Islam S" first="Salequl" last="Islam">Salequl Islam</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.</nlm:affiliation>
<country xml:lang="fr">Bangladesh</country>
<wicri:regionArea>Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342</wicri:regionArea>
<wicri:noRegion>Dhaka 1342</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jahan, Iffat" sort="Jahan, Iffat" uniqKey="Jahan I" first="Iffat" last="Jahan">Iffat Jahan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Physiology, Eastern Medical College, Cumilla, Bangladesh.</nlm:affiliation>
<country xml:lang="fr">Bangladesh</country>
<wicri:regionArea>Department of Physiology, Eastern Medical College, Cumilla</wicri:regionArea>
<wicri:noRegion>Cumilla</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Haque, Mainul" sort="Haque, Mainul" uniqKey="Haque M" first="Mainul" last="Haque">Mainul Haque</name>
<affiliation wicri:level="1"><nlm:affiliation>Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia.</nlm:affiliation>
<country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000</wicri:regionArea>
<wicri:noRegion>57000</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Infection and drug resistance</title>
<idno type="ISSN">1178-6973</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and quickly spread globally. Several treatments have been proposed, many of which have proven ineffective. Consequently, there is a need to review the published evidence of drug clinical trials to guide future prescribing. A systematic review of published clinical trials and retrospective observational studies was carried out. The search was made using PubMed, Embase, MEDLINE, and China National Knowledge Infrastructure (CNKI) databases. Articles published between January 2020 and October 2020 and written in the English language were retrieved and included in the study. Researches that used traditional medicine, in-vitro and in-vivo animal studies, as well as reviews were excluded. Seventy-three relevant articles that fulfilled the inclusion criteria were finally selected and reviewed. Hydroxychloroquine, chloroquine, and azithromycin produced no clinical evidence of efficacy in randomized controlled clinical trials (RCT). However, retrospective observational studies reported the efficacy of remdesivir and lopinavir/ritonavir in reducing viral load, although there have been concerns with lopinavir/ritonavir and, more recently, remdesivir. Recently, tocilizumab, dexamethasone, and methylprednisolone significantly relieved lung inflammation and decreased mortality in patients with severe COVID-19. In addition, convalescent plasma was effective in boosting strong immunity among patients with mild COVID-19. There is currently no single worldwide approved therapeutic option for patients with COVID-19 despite the initial hype with medicines, including hydroxychloroquine. Nonetheless, dexamethasone has shown promise in symptomatic treatment and convalescent plasma in boosting immunity. New treatments are currently being researched, and the findings will be reported accordingly to provide evidence-based guidance for prescribers and policymakers.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33402839</PMID>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN>
<JournalIssue CitedMedium="Print"><Volume>13</Volume>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Infection and drug resistance</Title>
<ISOAbbreviation>Infect Drug Resist</ISOAbbreviation>
</Journal>
<ArticleTitle>Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.</ArticleTitle>
<Pagination><MedlinePgn>4673-4695</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S289037</ELocationID>
<Abstract><AbstractText>A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and quickly spread globally. Several treatments have been proposed, many of which have proven ineffective. Consequently, there is a need to review the published evidence of drug clinical trials to guide future prescribing. A systematic review of published clinical trials and retrospective observational studies was carried out. The search was made using PubMed, Embase, MEDLINE, and China National Knowledge Infrastructure (CNKI) databases. Articles published between January 2020 and October 2020 and written in the English language were retrieved and included in the study. Researches that used traditional medicine, in-vitro and in-vivo animal studies, as well as reviews were excluded. Seventy-three relevant articles that fulfilled the inclusion criteria were finally selected and reviewed. Hydroxychloroquine, chloroquine, and azithromycin produced no clinical evidence of efficacy in randomized controlled clinical trials (RCT). However, retrospective observational studies reported the efficacy of remdesivir and lopinavir/ritonavir in reducing viral load, although there have been concerns with lopinavir/ritonavir and, more recently, remdesivir. Recently, tocilizumab, dexamethasone, and methylprednisolone significantly relieved lung inflammation and decreased mortality in patients with severe COVID-19. In addition, convalescent plasma was effective in boosting strong immunity among patients with mild COVID-19. There is currently no single worldwide approved therapeutic option for patients with COVID-19 despite the initial hype with medicines, including hydroxychloroquine. Nonetheless, dexamethasone has shown promise in symptomatic treatment and convalescent plasma in boosting immunity. New treatments are currently being researched, and the findings will be reported accordingly to provide evidence-based guidance for prescribers and policymakers.</AbstractText>
<CopyrightInformation>© 2020 Abubakar et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abubakar</LastName>
<ForeName>Abdullahi Rabiu</ForeName>
<Initials>AR</Initials>
<Identifier Source="ORCID">0000-0002-9740-7856</Identifier>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sani</LastName>
<ForeName>Ibrahim Haruna</ForeName>
<Initials>IH</Initials>
<Identifier Source="ORCID">0000-0003-1153-5900</Identifier>
<AffiliationInfo><Affiliation>Unit of Pharmacology, College of Health Sciences, Yusuf Maitama Sule University, Kano, Nigeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Godman</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
<Identifier Source="ORCID">0000-0001-6539-6972</Identifier>
<AffiliationInfo><Affiliation>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kumar</LastName>
<ForeName>Santosh</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-5117-7872</Identifier>
<AffiliationInfo><Affiliation>Department of Periodontology and Implantology, Karnavati University, Gandhinagar 382422, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Islam</LastName>
<ForeName>Salequl</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0001-6131-4132</Identifier>
<AffiliationInfo><Affiliation>Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jahan</LastName>
<ForeName>Iffat</ForeName>
<Initials>I</Initials>
<Identifier Source="ORCID">0000-0003-0551-3609</Identifier>
<AffiliationInfo><Affiliation>Department of Physiology, Eastern Medical College, Cumilla, Bangladesh.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Haque</LastName>
<ForeName>Mainul</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0002-6124-7993</Identifier>
<AffiliationInfo><Affiliation>Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, 57000, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>New Zealand</Country>
<MedlineTA>Infect Drug Resist</MedlineTA>
<NlmUniqueID>101550216</NlmUniqueID>
<ISSNLinking>1178-6973</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">clinical-trials</Keyword>
<Keyword MajorTopicYN="N">dexamethasone</Keyword>
<Keyword MajorTopicYN="N">efficacy</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">lopinavir/ritonavir</Keyword>
<Keyword MajorTopicYN="N">remdesivir</Keyword>
<Keyword MajorTopicYN="N">therapeutic-option</Keyword>
</KeywordList>
<CoiStatement>The authors report no conflicts of interest for this work and declare that they do not have any financial involvement or affiliations with any organization, association, or entity directly or indirectly with the subject matter or materials presented in this article. This also includes honoraria, expert testimony, employment, ownership of stocks or options, patents or grants received or pending, or royalties.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>10</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>6</Day>
<Hour>5</Hour>
<Minute>52</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33402839</ArticleId>
<ArticleId IdType="doi">10.2147/IDR.S289037</ArticleId>
<ArticleId IdType="pii">289037</ArticleId>
<ArticleId IdType="pmc">PMC7778508</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2020 Aug;97:396-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32623082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Aug;2(8):e474-e484</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32835257</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Jul - Aug;36:101632</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205269</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3390-3396</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32271456</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2020 Sep;26(9):1276-1277</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32422406</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jun;92(6):568-576</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32134116</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Aug 01;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32738143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Sep 15;324(11):1048-1057</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32821939</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32191691</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Autoimmun Rev. 2020 Jul;19(7):102568</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32376398</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32401715</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33262668</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1425-1433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32407884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 11;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32651997</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2021 Jan 1;181(1):9-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32945833</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infez Med. 2020 Sep 1;28(3):357-366</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32920571</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32391667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Sep;56(3):106101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32687949</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Sep 4;370:m3379</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32887691</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Discov. 2020 Feb 24;6:11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32133153</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pharmacol. 2020 Nov 5;886:173451</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32768505</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Glob Health. 2020 Oct;8(10):e1264-e1272</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32687792</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acad Emerg Med. 2020 Jun;27(6):493-504</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32359203</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Oct 19;371:m4057</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33077424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Engineering (Beijing). 2020 Oct;6(10):1185-1191</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32923016</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2021 Jan 1;181(1):41-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33080002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32267544</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Intern Med. 2020 Jun;76:36-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32448770</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Oct 20;173(8):623-631</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32673060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2021 Jan 1;181(1):24-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33080005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2020 May 11;15(5):e0233147</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32392262</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EClinicalMedicine. 2020 Aug;25:100459</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Pharmacol. 2020 Nov 06;11:588654</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33240091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jul;92(7):814-818</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32253759</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2020 Aug 20;15(8):e0237831</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32817707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Jul;81(1):e1-e5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Sep;56(3):106103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32712333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32289548</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cleve Clin J Med. 2020 Sep 2;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32371558</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Oct;2(10):e603-e612</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32323646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32359035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1015-1018</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32197103</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Autoimmun. 2020 Nov;114:102523</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32690352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Microbiol. 2020 Aug;69(8):1114-1123</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32783802</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Jul - Aug;36:101791</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32593867</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1673-1680</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32905939</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microorganisms. 2020 May 09;8(5):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32397399</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Oct 6;324(13):1330-1341</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32876694</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2020 Oct 1;222(9):1575-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32777038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Open Forum Infect Dis. 2020 Apr 15;7(4):ofaa130</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32363212</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Jul;2(7):e379-e381</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32835233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Epidemiol Glob Health. 2021 Jan-Mar;9:123-127</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EClinicalMedicine. 2020 Jun 20;24:100418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32766537</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Nei Ke Za Zhi. 2020 May 09;59(0):E012</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32388937</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Med. 2020 Feb 20;9(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32093211</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Health Econ Health Policy. 2014 Feb;12(1):19-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24385261</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2020 Jul 6;192(27):E734-E744</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32493740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32640463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Aug 09;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32770240</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2021 Feb;93(2):831-842</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32672860</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2020 Aug 13;15(8):e0237693</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32790733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian J Med Ethics. 2020 Apr-Jun;V(2):103-105</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32393447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 16;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32674126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32334395</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Syst Rev. 2015 Jan 01;4:1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25554246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):589-596</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32417708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dev Ctries. 2020 Aug 31;14(8):838-843</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32903226</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 May - Jun;35:101738</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32387409</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med (N Y). 2020 Dec 18;1(1):114-127.e3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838355</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ther Adv Endocrinol Metab. 2018 Jun 22;9(8):241-254</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30181850</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Asian J Psychiatr. 2020 Dec;54:102203</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32603983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med (N Y). 2020 Dec 18;1(1):105-113.e4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Int AIDS Soc. 2020 Apr;23(4):e25489</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32293807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hosp Infect. 2018 Oct;100(2):222-235</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29902486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart. 2020 Oct;106(19):1503-1511</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32737124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Nov;92(11):2813-2820</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32628003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virusdisease. 2020 Jun;31(2):161-173</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32656310</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Mar;8(3):267-276</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32043986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2020;2203:1-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32833200</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Glob Health Action. 2020 Dec 31;13(1):1776526</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32588779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2020 Nov 5;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33161150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Jul 30;370:m2980</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32732190</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2020 Nov 17;64(12):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32958718</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Rep. 2020 Dec;72(6):1479-1508</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32889701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32350134</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2020 Aug;190(8):1680-1690</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32473109</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32253318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Dis Poverty. 2020 Mar 17;9(1):29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32183901</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Sep 15;324(11):1041-1042</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32821934</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Rheum Dis. 2020 May;23(5):613-619</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32281213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 2;395(10234):1421-1422</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32330427</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Patient. 2018 Aug;11(4):377-389</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29322308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Jun 27;395(10242):1973-1987</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32497510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Oct 3;396(10256):959-967</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32896292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Z Gesundh Wiss. 2020 Jun 13;:1-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32837842</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Oct 22;371:m3939</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33093056</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Res. 2020 Jul;157:104872</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32360583</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Apr 20;369:m1548</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32312785</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Crit Care. 2020 Jun;57:279-283</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32173110</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Drug Investig. 2020 Jul;40(7):591-601</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32468425</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2020 Oct;158(4):1397-1408</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32553536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Pharmacol. 2020 Sep 11;11:1205</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33071775</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2020 Dec 2;15(12):e0242763</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33264337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biomed Pharmacother. 2020 Nov;131:110668</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32861965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Saf. 2020 Dec;43(12):1315-1322</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33078372</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32445440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):641-648</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32428865</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Aff (Millwood). 2020 Jul;39(7):1237-1246</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32407171</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 19;383(21):2041-2052</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32706953</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Clin Pharmacol. 2020 Dec 29;:1-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33252992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Apr 8;369:m1432</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32269046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2015;1282:1-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25720466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Res Perspect. 2020 Dec;8(6):e00666</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33084232</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tob Induc Dis. 2020 Mar 20;18:20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32206052</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Intern Med. 2020 Jun;76:43-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32482597</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jul 17;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2020 Aug;50(5):397-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32387320</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2020 Jul;26(7):917-921</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32344167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Environ Res Public Health. 2020 Apr 30;17(9):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32365851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2020 Apr 10;21(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32290293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 30;395(10238):1678-1680</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32401713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2020 May 7;55(5):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32269088</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2020 Sep 22;15(9):e0239401</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32960899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Jun;2(6):e325-e331</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32501454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 5;383(19):1886-1887</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32459913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EClinicalMedicine. 2020 Jul 01;24:100410</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32766535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Apr 14;323(14):1341-1342</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32125371</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Bangladesh</li>
<li>Inde</li>
<li>Malaisie</li>
<li>Nigeria</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Nigeria"><noRegion><name sortKey="Abubakar, Abdullahi Rabiu" sort="Abubakar, Abdullahi Rabiu" uniqKey="Abubakar A" first="Abdullahi Rabiu" last="Abubakar">Abdullahi Rabiu Abubakar</name>
</noRegion>
<name sortKey="Sani, Ibrahim Haruna" sort="Sani, Ibrahim Haruna" uniqKey="Sani I" first="Ibrahim Haruna" last="Sani">Ibrahim Haruna Sani</name>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Godman, Brian" sort="Godman, Brian" uniqKey="Godman B" first="Brian" last="Godman">Brian Godman</name>
</noRegion>
</country>
<country name="Inde"><noRegion><name sortKey="Kumar, Santosh" sort="Kumar, Santosh" uniqKey="Kumar S" first="Santosh" last="Kumar">Santosh Kumar</name>
</noRegion>
</country>
<country name="Bangladesh"><noRegion><name sortKey="Islam, Salequl" sort="Islam, Salequl" uniqKey="Islam S" first="Salequl" last="Islam">Salequl Islam</name>
</noRegion>
<name sortKey="Jahan, Iffat" sort="Jahan, Iffat" uniqKey="Jahan I" first="Iffat" last="Jahan">Iffat Jahan</name>
</country>
<country name="Malaisie"><noRegion><name sortKey="Haque, Mainul" sort="Haque, Mainul" uniqKey="Haque M" first="Mainul" last="Haque">Mainul Haque</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B78 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B78 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:33402839 |texte= Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33402839" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |